ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,089Medicare Part D Prescriptions Filled, Including Refills

Rank: 525 out of 2888

$584K Total Retail Price of All Prescriptions

Rank: 659 out of 2888

749 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 749 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

12% of this provider’s 749 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 9,692 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 645 628 1 2
HYDROCODONE-ACETAMINOPHEN 438 407 S3 2 4
LISINOPRIL 429 424 3 3
LEVOTHYROXINE SODIUM 405 390 4 1
FLUTICASONE PROPIONATE 316 304 5 32
ZOLPIDEM TARTRATE 287 273 6 17
ATENOLOL 277 264 7 25
AMLODIPINE BESYLATE 276 271 8 5
ATORVASTATIN CALCIUM 243 232 9 9
METFORMIN HCL 235 235 10 8
WARFARIN SODIUM 235 230 10 22
HYDROCHLOROTHIAZIDE 202 199 12 15
GABAPENTIN 189 176 13 13
METOPROLOL TARTRATE 185 185 14 10
OMEPRAZOLE 175 165 15 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 174 174 16 28
TAMSULOSIN HCL 165 159 17 29
FUROSEMIDE 164 157 18 6
METOPROLOL SUCCINATE 137 137 19 11
LOSARTAN POTASSIUM 137 137 19 18
TRAZODONE HCL 129 124 21 43
LOSARTAN-HYDROCHLOROTHIAZIDE 118 114 22 46
CITALOPRAM HBR 113 112 23 24
FINASTERIDE 111 109 24 102
GLYBURIDE 107 106 R 25 58
TRIAMTERENE-HCTZ 102 99 26 63
TRAMADOL HCL 97 89 27 16
AZITHROMYCIN 92 85 28 38
CRESTOR 81 78 29 20
ALLOPURINOL 80 76 30 37
POTASSIUM CHLORIDE 78 78 31 14
MIRTAZAPINE 76 76 32 54
SPIRONOLACTONE 75 71 33 70
DIGOXIN 72 72 34 55
METHYLPREDNISOLONE 70 70 35 101
ALENDRONATE SODIUM 66 66 36 23
CIPROFLOXACIN HCL 64 62 37 47
JANUVIA 60 60 38 48
VYTORIN 55 55 39 155
RANITIDINE HCL 54 54 40 56
DOXAZOSIN MESYLATE 54 54 40 94
PREMARIN 53 47 R 42 129
VENLAFAXINE HCL ER 52 45 43 120
FLUOXETINE HCL 52 43 43 83
VENTOLIN HFA 50 50 45 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.